CALR c.763G>A ;(p.E255K)

Variant ID: 19-13051415-G-A

NM_004343.3(CALR):c.763G>A;(p.E255K)

This variant was identified in 5 publications

View GRCh38 version.




Publications:


Interrogating the molecular genetics of chronic myeloproliferative malignancies for personalized management in 2021.

Haematologica
Mughal, Tariq I TI; Psaila, Bethan B; DeAngelo, Daniel J DJ; Saglio, Giuseppe G; Van Etten, Richard A RA; Radich, Jerald P JP
Publication Date: 2021-07-01

Variant appearance in text: CALR: E255K
PubMed Link: 33657787
Variant Present in the following documents:
  • Main text
  • 1061787.pdf
View BVdb publication page



Neoantigens in Hematologic Malignancies.

Frontiers In Immunology
Biernacki, Melinda A MA; Bleakley, Marie M
Publication Date: 2020

Variant appearance in text: CALR: E255K
PubMed Link: 32117272
Variant Present in the following documents:
  • Main text
  • fimmu-11-00121.pdf
View BVdb publication page



High-intensity sequencing reveals the sources of plasma circulating cell-free DNA variants.

Nature Medicine
Razavi, Pedram P; Li, Bob T BT; Brown, David N DN; Jung, Byoungsok B; Hubbell, Earl E; Shen, Ronglai R; Abida, Wassim W; Juluru, Krishna K; De Bruijn, Ino I; Hou, Chenlu C; Venn, Oliver O; Lim, Raymond R; Anand, Aseem A; Maddala, Tara T; Gnerre, Sante S; Vijaya Satya, Ravi R; Liu, Qinwen Q; Shen, Ling L; Eattock, Nicholas N; Yue, Jeanne J; Blocker, Alexander W AW; Lee, Mark M; Sehnert, Amy A; Xu, Hui H; Hall, Megan P MP; Santiago-Zayas, Angie A; Novotny, William F WF; Isbell, James M JM; Rusch, Valerie W VW; Plitas, George G; Heerdt, Alexandra S AS; Ladanyi, Marc M; Hyman, David M DM; Jones, David R DR; Morrow, Monica M; Riely, Gregory J GJ; Scher, Howard I HI; Rudin, Charles M CM; Robson, Mark E ME; Diaz, Luis A LA; Solit, David B DB; Aravanis, Alexander M AM; Reis-Filho, Jorge S JS
Publication Date: 2019-12

Variant appearance in text: CALR: 763G>A; Glu255Lys
PubMed Link: 31768066
Variant Present in the following documents:
  • NIHMS1541314-supplement-1541314_Sup_Tab.xlsx, sheet 4
  • NIHMS1541314-supplement-1541314_Sup_Tab.xlsx, sheet 6
  • NIHMS1541314-supplement-1541314_SourceDataFig1.xlsx, sheet 4
View BVdb publication page



Analysis of clinical characteristics and efficacy of chronic myeloid leukemia onset with extreme thrombocytosis in the era of tyrosine kinase inhibitors.

Oncotargets And Therapy
Liu, Zhihe Z; Fan, Hongqiong H; Li, Yuying Y; Liu, Chunshui C
Publication Date: 2017

Variant appearance in text: CALR: E255K
PubMed Link: 28761360
Variant Present in the following documents:
  • Main text
  • ott-10-3515.pdf
View BVdb publication page



BCR/ABL and other kinases from chronic myeloproliferative disorders stimulate single-strand annealing, an unfaithful DNA double-strand break repair.

Cancer Research
Cramer, Kimberly K; Nieborowska-Skorska, Margaret M; Koptyra, Mateusz M; Slupianek, Artur A; Penserga, Emir Tyrone P ET; Eaves, Connie J CJ; Aulitzky, Walter W; Skorski, Tomasz T
Publication Date: 2008-09-01

Variant appearance in text: SSA: E255K
PubMed Link: 18757400
Variant Present in the following documents:
  • Main text
View BVdb publication page